Study #PA16-0928
Genetic Determinants of Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibition Therapy
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibition Therapy
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Maria Suarez-Almazor
Department:
Health Services Research
For general questions about clinical trials:
1-888-912-0153
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.